| Name | Title | Contact Details |
|---|
Commencement Bank, headquartered in Tacoma, WA, was formed in 2006. We provide traditional, reliable, and sustainable banking in Pierce County, South King County, Thurston County and the surrounding areas. Our team of experienced banking experts focuses on personal attention, flexible service, and building strong relationships with customers. As a local bank, Commencement Bank is deeply committed to the community.
Turn One is a manufacturer of high performance power steering boxes, pumps, pulleys and accessories. We also offer rebuilding services for power steering boxes, pumps, and rack & pinion assemblies. Delivering the highest quality parts for drivers that demand the best in steering performance!
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.